YARROW BIOSCIENCE, INC. Unrealized Gain (Loss) on Investments
YARROW BIOSCIENCE, INC. (YARW) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-06-03
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for the quarter ending 2024-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for the quarter ending 2024-03-31 was $1.00K.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for fiscal 2023 was -$1.00K.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for fiscal 2022 was $0.00.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. unrealized gain (loss) on investments for fiscal 2020 was $142.00K, a 60.22% decline from fiscal 2019.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $1.00K S-4/A · filed 2026-06-03 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$1.00K 10-K · filed 2025-03-06 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | -$11.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | -$11.00K derived: sum of 3 quarters · filed 2022-03-17 | $142.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$11.00K derived: sum of 2 quarters · filed 2021-11-10 | $142.00K 10-Q · filed 2021-11-10 | $230.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $142.00K 10-Q · filed 2021-08-12 | $230.00K derived: sum of 3 quarters · filed 2021-08-12 | $141.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $153.00K 10-Q · filed 2021-05-06 | $241.00K derived: sum of 2 quarters · filed 2021-05-06 | $152.00K derived: sum of 3 quarters · filed 2021-05-06 | $246.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$1.00K derived: sum of 2 quarters · filed 2021-03-04 | $93.00K derived: sum of 3 quarters · filed 2021-03-04 | $357.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $5.00K derived: sum of 2 quarters · filed 2020-11-05 | $269.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $358.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $264.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$201.00K 10-K · filed 2021-03-04 | |||
| 2017-12-31 | $25.00K 10-K · filed 2018-03-28 | |||
| 2016-12-31 | $26.00K 10-K · filed 2018-03-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |